{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:58:21Z","timestamp":1787061501917,"version":"build-2736575974"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009242","name":"Direction de l\u2019hospitalisation et de l\u2019offre de Soins","doi-asserted-by":"publisher","award":["PHRC-12-009-0243"],"award-info":[{"award-number":["PHRC-12-009-0243"]}],"id":[{"id":"10.13039\/501100009242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0237022","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T13:29:11Z","timestamp":1596806951000},"page":"e0237022","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study"],"prefix":"10.1371","volume":"15","author":[{"given":"Jacques","family":"Bouget","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Balusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Viglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Lacut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Pavageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-2977","authenticated-orcid":true,"given":"Emmanuel","family":"Oger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"issue":"2 suppl","key":"pone.0237022.ref001","first-page":"e89S","article-title":"Antiplatelet drugs. Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"JW Eikelboom","year":"2012","journal-title":"Chest"},{"issue":"2 suppl","key":"pone.0237022.ref002","first-page":"e669S","article-title":"Antithrombotic therapy in peripheral artery disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"P Alonso-Coello","year":"2012","journal-title":"Chest"},{"issue":"2 suppl","key":"pone.0237022.ref003","first-page":"e601S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke. Antithrombotic therapy in peripheral artery disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"MG Lansberg","year":"2012","journal-title":"Chest"},{"key":"pone.0237022.ref004","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"on behalf of the American heart association stroke council","year":"2014","journal-title":"Stroke"},{"issue":"2 suppl","key":"pone.0237022.ref005","first-page":"e637S","article-title":"Primary and secondary prevention of cardiovascular disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"PO Vandvik","year":"2012","journal-title":"Chest"},{"issue":"3","key":"pone.0237022.ref006","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients without persistent ST-segment elevation of the European society of cardiology (ESC)","volume":"37","author":"M Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"pone.0237022.ref007","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events. A systematic review and meta-analysis","volume":"321","author":"SL Zheng","year":"2019","journal-title":"JAMA"},{"issue":"16","key":"pone.0237022.ref008","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"for the ASPREE investigator group","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0237022.ref009","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","article-title":"Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study","volume":"390","author":"on behalf of the Oxford Vascular study","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"pone.0237022.ref010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1155\/2013\/596015","article-title":"Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies","volume":"27","author":"VE Valkhoff","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"pone.0237022.ref011","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1212\/WNL.0000000000004694","article-title":"Low-dose aspirin and risk of intracranial bleeds. An observational study in UK general practice","volume":"89","author":"L Cea Soriano","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"pone.0237022.ref012","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ehjcvp\/pvw011","article-title":"Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients","volume":"2","author":"G Savarese","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"pone.0237022.ref013","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials","volume":"373","author":"Antithrombotic Trialists\u2019 (ATT) Collaboration","year":"2009","journal-title":"Lancet"},{"key":"pone.0237022.ref014","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/jamaneurol.2018.2215","article-title":"Association of intracranial haemorrhage risk with non-vitamin K antagonist oral anticoagulant use vs. aspirin use: a systematic review and meta-analysis","volume":"75","author":"WY Huang","year":"2018","journal-title":"JAMA Neurol"},{"key":"pone.0237022.ref015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): a randomized, double-blind, placebo-controlled trial","volume":"364","author":"on behalf of the MATCH investigators","year":"2004","journal-title":"Lancet"},{"key":"pone.0237022.ref016","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"for the CHARISMA investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"pone.0237022.ref017","first-page":"378","article-title":"Causes of late mortality with dual antiplatelet therapy after coronary stents","volume":"37","author":"for the DAPT study investigators","year":"2016","journal-title":"Eur Heart J"},{"key":"pone.0237022.ref018","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/fcp.12444","article-title":"Major bleeding with antithrombotic drugs: a 2012\u20132015 study using the French nationwide Health Insurance database linked to emergency department records within five areas. Rationale and design of SACHA study","volume":"33","author":"J Bouget","year":"2019","journal-title":"Fund Clin Pharmacol"},{"key":"pone.0237022.ref019","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","article-title":"The best use of the Charlson comorbidity index with electronic health care database to predict mortality","volume":"54","author":"A Bannay","year":"2016","journal-title":"Med Care"},{"key":"pone.0237022.ref020","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"for the Subcommittee on Control of Anticoagulation","year":"2015","journal-title":"J Thromb Haemost"},{"key":"pone.0237022.ref021","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"PC Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"pone.0237022.ref022","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"SR Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pone.0237022.ref023","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12874-019-0841-6","article-title":"Sensitivity and specificity of an algorithm based on medico-administrative data to identify hospitalized patients with major bleeding presenting to an emergency department","volume":"19","author":"E Oger","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"pone.0237022.ref024","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemic events","volume":"338","author":"The SALT collaborative group","year":"1991","journal-title":"Lancet"},{"key":"pone.0237022.ref025","article-title":"Oral antiplatelet therapy for acute ischaemic stroke","volume":"26","author":"PAG Sandercock","year":"2014","journal-title":"Cochrane database Syst Rev"},{"key":"pone.0237022.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2015.12.013","article-title":"Risk of major bleeding in patients receiving vitamin K antagonists or low doses of aspirin. A systematic review and meta-analysis","volume":"138","author":"FJ Vazquez","year":"2016","journal-title":"Thromb Res"},{"key":"pone.0237022.ref027","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials. A consensus report from the bleeding academic research consortium","volume":"123","author":"R Mehran","year":"2011","journal-title":"Circulation"},{"key":"pone.0237022.ref028","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cgh.2014.11.007","article-title":"Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants","volume":"13","author":"A Lanas","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0237022.ref029","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/pds.4668","article-title":"Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome","volume":"27","author":"J Spoendlin","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"pone.0237022.ref030","doi-asserted-by":"crossref","first-page":"e0175283","DOI":"10.1371\/journal.pone.0175283","article-title":"Efficacy and safety of aspirin in patients with peripheral vascular disease: an updated systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"AN Mahmoud","year":"2017","journal-title":"PLoS One"},{"key":"pone.0237022.ref031","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1212\/WNL.0000000000004997","article-title":"Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke","volume":"90","author":"on behalf of the CAT collaboration","year":"2018","journal-title":"Neurology"},{"key":"pone.0237022.ref032","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"368","author":"The SPS3 investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"pone.0237022.ref033","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/ene.13695","article-title":"Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis","volume":"25","author":"L Ding","year":"2018","journal-title":"Eur J Neurol"},{"key":"pone.0237022.ref034","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"for the Clinical Research Collaboration Neurological Emergencies Treatment Trials Network and the POINT Investigators","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0237022.ref035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ahj.2011.04.015","article-title":"Bleeding, mortality, and antiplatelet therapy: results from the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial","volume":"162","author":"JS Berger","year":"2011","journal-title":"Am Heart J"},{"key":"pone.0237022.ref036","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"for the TRITON-TIMI 38 investigators","year":"2007","journal-title":"N Engl J Med"},{"key":"pone.0237022.ref037","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"for the PLATO investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"pone.0237022.ref038","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jamaneurol.2019.0932","article-title":"Risk for major hemorrhages in patients receiving clopidogrel and aspirin compared with aspirin alone after transient ischemic attack or minor ischemic stroke. A secondary analysis of the POINT randomized clinical trial","volume":"76","author":"H Tillman","year":"2019","journal-title":"JAMA Neurology"},{"key":"pone.0237022.ref039","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.110.973008","article-title":"Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications","volume":"123","author":"LA Garcia Rodriguez","year":"2011","journal-title":"Circulation"},{"key":"pone.0237022.ref040","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes. Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","volume":"108","author":"for the Clopidogrel in Unstable angina to prevent Recurrent events (CURE) trial investigators","year":"2003","journal-title":"Circulation"},{"key":"pone.0237022.ref041","article-title":"Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: clinical translation and areas of research","author":"A Di Minno","year":"2015","journal-title":"Blood Reviews"},{"key":"pone.0237022.ref042","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"Caprie Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"pone.0237022.ref043","first-page":"1510","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"for the ASPREE investigator group","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0237022.ref044","article-title":"Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs","author":"S Pannach","year":"2017","journal-title":"J Gastroenterol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T13:29:31Z","timestamp":1596806971000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237022"}},"subtitle":[],"editor":[{"given":"Timir","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0237022","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]}}}